Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-23-095018

Director acquired 500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peters Richard Director 2023-08-23 Grant or award +500 1,029 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Peters Richard Director 2023-08-23 Grant or award · Stock Options (Right to Buy) +2,000 2,000 D: show line 2 in the form
Loading xslF345X05/tm2324788-5_4seq1.xml…